Skip to content

Virtual Reality for Medial Epicondyle Apophysitis

The Efficacy of Virtual Reality Training on Medial Epicondyle Apophysitis in Adolescent Athletes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07713342
Enrollment
60
Registered
2026-07-20
Start date
2026-07-20
Completion date
2026-10-20
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent Athelets, Medial Epicondyle Apophysitis

Keywords

Medial Epicondyle Apophysitis, Virtual Reality,, strengthing exercise

Brief summary

Traction apophysitis of the medial epicondyle (MEC) is a common elbow injury in adolescent baseball players. The underlying pathology of the lesions associated with apophysitis seems to be due to repetitive traction stress via the medial ulnar collateral ligament (MUCL) to the skeletally immature MEC, as seen in young baseball players. Various types of morphological changes are observed at the MEC in baseball players, and fragmentation and hypertrophy have been commonly reported.

Detailed description

Phases of rehabilitation for Medial Epicondyle Apophysitis Phase I treatment involves resting and protecting the elbow to permit healing, to prevent further injury, and to control pain and swelling. Phase II treatment begins once pain and swelling have subsided to the point where the athlete can comfortably bear weight and walk from place to place. Virtual reality (VR) is a simulated experience that can be similar to or completely different from the real world. Applications of virtual reality can include entertainment (i.e. video games) and educational purposes (i.e. medical or military training). Other, distinct types of VR style technology include augmented reality and mixed reality.

Interventions

OTHERThe Control Group

All adolescents will receive 60 min. of the selected physical therapy program including strengthening the muscles of upper limb, stretching for elbow flexors and forearms pronators

all adolescents will receive selected physical therapy program for 30 min. containing strengthening the muscles of upper limb, stretching for elbow flexors and forearms pronators plus 30 of virtual reality training

Sponsors

South Valley University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Duple blinded (Outcomes Assessor, patients) Blinding process to participants and care providers was impossible due to the nature of intervention therapy. Data were analyzed by an impartial statistician (outcomes assessor), referring to each arm with an encoded name: Group 1 (control group) and Group 2 (virtual reality group),

Intervention model description

G 1 (control) received traditional physical therapy program for 60 min. G 2 (study) received traditional physical therapy program for 30 min. and virtual reality for 30 min. all groups treated for 3 successive months.

Eligibility

Sex/Gender
ALL
Age
12 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Cases diagnosed with medial epicondyle apophysitis. * Cases participated in this study will from both sexes. * Cases receiving standard treatment protocol. * Cases with a disease duration of more than four months.

Exclusion criteria

* Cases with resent fractures in affected upper limb. * Cases diagnosis of any neurological disease or musculoskeletal disease affecting upper extremity functional ability. * Uncooperative cases.

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scaleat day 0pain assessment tool, the scale ranged from 0-10 (at which 0 indicate no pain and 10 indicate sever pain)

Secondary

MeasureTime frameDescription
Range of Motionat day 0Elbow Flexion angle degree

Countries

Egypt

Contacts

CONTACTNehad A Abo-zaid, Assistant Professor
dr.nehadahmed@svu.edu.eg01008980727
CONTACTOla A KamalLecturer, Lecturer
01118458838
PRINCIPAL_INVESTIGATORNehad A Abo-zaid, Assistant Professor

South Valley University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 21, 2026